Paper12962139
Comparison of Saw Palmetto (extract and whole berry) and Cernitin on prostate growth in rats.
Talpur N and 4 others. Mol Cell Biochem, 2003. Cited by 25 papers, by iCite.
Cite this record
ConductScience Library. Comparison of Saw Palmetto (extract and whole berry) and Cernitin on prostate growth in rats. Papers, record 12962139. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/12962139
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Comparison of Saw Palmetto (extract and whole berry) and Cernitin on prostate growth in rats.
- PubMed
Topics12
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Fruit | Major topic |
| Plant Extracts | Major topic |
| Prostate | Major topic |
| Androgens | |
| Animals | |
| Body Weight | |
| Cell Division | |
| Male | |
| Organ Size | |
| Pollen | |
| Rats | |
| Secale |
Source PubMed
References26
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 12092634 | Randomized trial of a combination of natural products (cernitin, saw palmetto, B-sitosterol, vitamin E) on symptoms of benign prostatic hyperplasia (BPH). | Int Urol Nephrol | 2001 | https://conductscience.org/library/papers/12092634 | PubMed |
| 2 | 1279214 | A randomized, placebo-controlled multicenter study of the efficacy and safety of terazosin in the treatment of benign prostatic hyperplasia. | J Urol | 1992 | https://conductscience.org/library/papers/1279214 | PubMed |
| 3 | 4170194 | [Use of "Cernilton" in patients with prostatic hypertrophy]. | Hinyokika Kiyo | 1967 | https://conductscience.org/library/papers/4170194 | PubMed |
| 4 | 1904229 | [Inhibition of arachidonic acid cascade by extract of rye pollen]. | Arzneimittelforschung | 1991 | https://conductscience.org/library/papers/1904229 | PubMed |
| 5 | 8876706 | Comparison of phytotherapy (Permixon) with finasteride in the treatment of benign prostate hyperplasia: a randomized international study of 1,098 patients. | Prostate | 1996 | https://conductscience.org/library/papers/8876706 | PubMed |
| 6 | 1696065 | [Clinical evaluation of Cernilton on benign prostatic hypertrophy--a multiple center double-blind study with Paraprost]. | Hinyokika Kiyo | 1990 | https://conductscience.org/library/papers/1696065 | PubMed |
| 7 | 8922564 | Serenoa repens (Permixon). A review of its pharmacology and therapeutic efficacy in benign prostatic hyperplasia. | Drugs Aging | 1996 | https://conductscience.org/library/papers/8922564 | PubMed |
| 8 | 1283370 | Scandinavian clinical study of finasteride in the treatment of benign prostatic hyperplasia. | Eur Urol | 1992 | https://conductscience.org/library/papers/1283370 | PubMed |
| 9 | 13928839 | [Preliminary research on the therapeutic effect of Cernilton on chronic prostatovesiculitis]. | Sven Lakartidn | 1962 | https://conductscience.org/library/papers/13928839 | PubMed |
| 10 | 2692777 | Treatment of chronic prostatitis and prostatodynia with pollen extract. | Br J Urol | 1989 | https://conductscience.org/library/papers/2692777 | PubMed |
| 11 | 1689172 | Role of alpha-adrenergic blockers in the treatment of benign prostatic hyperplasia. | Prostate Suppl | 1990 | https://conductscience.org/library/papers/1689172 | PubMed |
| 12 | 6708534 | Inhibition of androgen metabolism and binding by a liposterolic extract of "Serenoa repens B" in human foreskin fibroblasts. | J Steroid Biochem | 1984 | https://conductscience.org/library/papers/6708534 | PubMed |
| 13 | 1642680 | [Anti-inflammatory activity of sabal fruit extracts prepared with supercritical carbon dioxide. In vitro antagonists of cyclooxygenase and 5-lipoxygenase metabolism]. | Arzneimittelforschung | 1992 | https://conductscience.org/library/papers/1642680 | PubMed |
| 14 | 7684524 | Finasteride (MK-906) in the treatment of benign prostatic hyperplasia. The Finasteride Study Group. | Prostate | 1993 | https://conductscience.org/library/papers/7684524 | PubMed |
| 15 | 9001839 | The economics of benign prostatic hyperplasia treatment: a literature review. | Clin Ther | 1996 | https://conductscience.org/library/papers/9001839 | PubMed |
| 16 | 8499988 | Results of treatment with pollen extract (Cernilton N) in chronic prostatitis and prostatodynia. | Br J Urol | 1993 | https://conductscience.org/library/papers/8499988 | PubMed |
| 17 | 1383816 | The effect of finasteride in men with benign prostatic hyperplasia. The Finasteride Study Group. | N Engl J Med | 1992 | https://conductscience.org/library/papers/1383816 | PubMed |
| 18 | 11582591 | Effect of cernitin pollen-extract on experimental nonbacterial prostatitis in rats. | Prostate | 2001 | https://conductscience.org/library/papers/11582591 | PubMed |
| 19 | 1699628 | Treatment of outflow tract obstruction due to benign prostatic hyperplasia with the pollen extract, cernilton. A double-blind, placebo-controlled study. | Br J Urol | 1990 | https://conductscience.org/library/papers/1699628 | PubMed |
| 20 | 11856101 | Terazosin for treating symptomatic benign prostatic obstruction: a systematic review of efficacy and adverse effects. | BJU Int | 2002 | https://conductscience.org/library/papers/11856101 | PubMed |
Cited by10
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 25 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 35847835 | Evaluation of the Therapeutic Effect of the Traditional Herbal Medicine Atrifil and Oshagh Gum on Testosterone-Induced Benign Prostatic Hyperplasia in Wistar Rats. | Adv Urol | 2022 | https://conductscience.org/library/papers/35847835 | PubMed |
| 32481550 | The Effects of Aronia melanocarpa Extract on Testosterone-Induced Benign Prostatic Hyperplasia in Rats, and Quantitative Analysis of Major Constituents Depending on Extract Conditions. | Nutrients | 2020 | https://conductscience.org/library/papers/32481550 | PubMed |
| 31807332 | Use of saw palmetto (Serenoa repens) extract for benign prostatic hyperplasia. | Food Sci Biotechnol | 2019 | https://conductscience.org/library/papers/31807332 | PubMed |
| 31623582 | A phytosterol-enriched saw palmetto supercritical CO2 extract ameliorates testosterone-induced benign prostatic hyperplasia by regulating the inflammatory and apoptotic proteins in a rat model. | BMC Complement Altern Med | 2019 | https://conductscience.org/library/papers/31623582 | PubMed |
| 28431537 | The role of flower pollen extract in managing patients affected by chronic prostatitis/chronic pelvic pain syndrome: a comprehensive analysis of all published clinical trials. | BMC Urol | 2017 | https://conductscience.org/library/papers/28431537 | PubMed |
| 27272436 | Effect of Saw Palmetto Supplements on Androgen-Sensitive LNCaP Human Prostate Cancer Cell Number and Syrian Hamster Flank Organ Growth. | Evid Based Complement Alternat Med | 2016 | https://conductscience.org/library/papers/27272436 | PubMed |
| 26816707 | Phytotherapy: emerging therapeutic option in urologic disease. | Transl Androl Urol | 2012 | https://conductscience.org/library/papers/26816707 | PubMed |
| 26106434 | Shrinkage of Prostate and Improved Quality of Life: Management of BPH Patients with Croton membranaceus Ethanolic Root Extract. | Evid Based Complement Alternat Med | 2015 | https://conductscience.org/library/papers/26106434 | PubMed |
| 24067389 | Fatty acid and phytosterol content of commercial saw palmetto supplements. | Nutrients | 2013 | https://conductscience.org/library/papers/24067389 | PubMed |
| 18038253 | Efficacy and safety of a combination of Sabal and Urtica extract in lower urinary tract symptoms--long-term follow-up of a placebo-controlled, double-blind, multicenter trial. | Int Urol Nephrol | 2007 | https://conductscience.org/library/papers/18038253 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/12962139
GET https://conductscience.org/api/papers/v1/12962139/references?page=2